4104 — Excelsior Medical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Annual cashflow statement for Excelsior Medical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	829	874	964	1,144	1,174
Depreciation
Amortisation
Non-Cash Items	-266	-241	-309	-430	-400
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	139	110	-240	-872	1,396
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	869	945	637	107	2,471
Capital Expenditures	-35	-169	-173	-143	-121
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-380	313	-518	248	55.1
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-415	144	-690	106	-65.6
Financing Cash Flow Items	166	-95.7	-112	-65.6	-46
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-603	-594	-634	-105	-956
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-210	454	-565	108	1,574